Home / Uncategorized

FANCI: a new gene at the origin of some cases of ovarian cancer

Ovarian cancer affects approximately 3000 women per year in Canada. Although most cases are sporadic, there are hereditary forms of ovarian cancer that are largely attributed to mutations in the

‘All hands on deck’: Montreal scientists step up in urgent COVID-19 variant hunt


McGill team wins grant to study ‘trained immunity’ with Japanese researchers

Joint research program between the Japan Agency for Medical Research and Development and the Canadian Institutes of Health Research focuses on advancing technologies in epigenomics, deepening McGill’s relationship with Japan’s

Deux biobanques pour lutter contre la COVID-19

Face à la pandémie de COVID-19, deux biobanques ont rapidement été mises sur pied pour faciliter la recherche. Comment en apprendre davantage sur le virus SARS-CoV-2 et ses impacts sur

The COVID-19 Genomics UK (COG-UK) consortium and the Canadian COVID Genomics Network (CanCOGeN) launch new partnership

COG-UK and CanCOGeN are working together to share knowledge and protocols  The COVID-19 Genomics UK (COG-UK) consortium is collaborating with the newly formed Canadian COVID Genomics Network (CanCOGeN) as it launches a

Social Science and Humanities researchers also active in battle against COVID

McGill’s SSHRC Institutional Grant and MI4 co-fund 12 projects exploring the social dimension of the COVID-19 pandemic. Twelve McGill researchers are the recipients of a total of $179,258 in one-time

The Quebec COVID-19 Biobank – an essential weapon against COVID

Inter-institutional initiative is similar to other efforts abroad to catalogue samples gathered from COVID-19 patients, but the quality of the data and samples, as well as the long-term focus of

L’INSPQ et le Centre de génomique de McGill : partenaires pour le séquençage génétique du SARS-CoV-2 au Québec

L’Institut national de santé publique du Québec se joint au Centre de génomique de l’Université McGill afin de séquencer les différentes souches virales des patients québécois atteints par la COVID-19.

Des tests sanguins nécessaires : entrevue avec Vincent Poitout, directeur de la recherche du CHUM


Le groupe sanguin influe-t-il sur la sévérité de la COVID-19?

Q: «On dit que les gens du type O négatif sont plus résistants face à ce virus. Qu’en est-il vraiment?», demande Charles St-Amand. https://www.latribune.ca/actualites/vos-questions-sur-la-covid-19/le-groupe-sanguin-influe-t-il-sur-la-severite-de-la-covid-19-f9efccedd1146a79cb55bc575e72684f